Literature DB >> 4164259

Immunopathologic studies of systemic lupus erythematosus (SLE). I. Tissue-bound immunoglobulins in relation to serum antinuclear immunoglobulins in systemic lupus and in chronic liver disease with LE cell factor.

K H Svec, J D Blair, M H Kaplan.   

Abstract

We studied the composition of tissue-bound immunoglobulins and of antinuclear factors by immunofluorescent techniques in five patients with systemic lupus and two with chronic liver disease associated with positive LE cell tests. Renal glomeruli in all seven demonstrated deposits of bound gammaG-globulin and complement, although the presence of gammaA- and gammaM-immunoglobulins was variable. Blood vessel walls contained primarily gammaG-globulin and complement in the systemic lupus patients, but such deposits were absent from vessels in the two with chronic liver disease. We observed antinuclear factors, demonstrated by immunofluorescence, in all three immunoglobulin classes. In six of the seven patients, evidence was obtained of a correspondence between the classes of bound immunoglobulins in glomeruli and vessels and the serum titers of antinuclear immunoglobulins. These observations are consistent with the concept that immunoglobulin deposits in tissues may be derived at least in part from antinuclear factors. Neither bound immunoglobulins nor complement was observed in liver parenchyma of the two patients with chronic liver disease or in two patients with systemic lupus and liver pathology. It thus seems doubtful that serum antibodies play a primary role in the pathogenesis of forms of chronic liver disease associated with positive LE cell tests.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4164259      PMCID: PMC442039          DOI: 10.1172/JCI105557

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  LUPOID HEPATITIS.

Authors:  T B REYNOLDS; H A EDMONDSON; R L PETERS; A REDEKER
Journal:  Ann Intern Med       Date:  1964-10       Impact factor: 25.391

2.  GAMMA-2, GAMMA-1A AND GAMMA-1M ANTINUCLEAR FACTORS IN HUMAN SERA.

Authors:  E V BARNETT; J J CONDEMI; J P LEDDY; J H VAUGHAN
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

3.  DEPOSITION OF AUTOLOGOUS GAMMA GLOBULIN IN KIDNEYS OF RATS WITH NEPHROTIC RENAL DISEASE OF VARIOUS ETIOLOGIES.

Authors:  R OKUDA; M H KAPLAN; F E CUPPAGE; W HEYMANN
Journal:  J Lab Clin Med       Date:  1965-08

4.  Systemic lupus erythematosus. Cryoprecipitation of sera.

Authors:  C L CHRISTIAN; W B HATFIELD; P H CHASE
Journal:  J Clin Invest       Date:  1963-06       Impact factor: 14.808

5.  A simple chromatographic method for preparation of gamma globulin.

Authors:  H B LEVY; H A SOBER
Journal:  Proc Soc Exp Biol Med       Date:  1960-01

6.  Hepatitis complicated by manifestations of lupus erythematosus.

Authors:  L I TAFT; I R MACKAY; L LARKIN
Journal:  J Pathol Bacteriol       Date:  1958-04

7.  Pathogenesis of serum sickness.

Authors:  F J DIXON; J J VAZQUEZ; W O WEIGLE; C G COCHRANE
Journal:  AMA Arch Pathol       Date:  1958-01

8.  An autoimmune reaction against human tissue antigens in certain acute and chronic diseases. I. Serological investigations.

Authors:  D C GAJDUSEK
Journal:  AMA Arch Intern Med       Date:  1958-01

9.  Some factors influencing the formation of L.E. cells; a method for enhancing L.E. cell production.

Authors:  W H ZINKHAM; C L CONLEY
Journal:  Bull Johns Hopkins Hosp       Date:  1956-02

10.  The response of serum gamma globulin level and complement titer to adrenocorticotropic hormone therapy in lupus erythematosus disseminatus.

Authors:  J H VAUGHAN; T B BAYLES; C B FAVOUR
Journal:  J Lab Clin Med       Date:  1951-05
View more
  9 in total

1.  Chorioretinopathy in a case of systemic lupus erythematosus.

Authors:  K R Diddie; A J Aronson; J T Ernest
Journal:  Trans Am Ophthalmol Soc       Date:  1977

2.  Ocular findings in systemic lupus erythematosus.

Authors:  D H Gold; D A Morris; P Henkind
Journal:  Br J Ophthalmol       Date:  1972-11       Impact factor: 4.638

3.  Nuclear deposits of immunoglobulins in skin of patients with systemic lupus erythematosus.

Authors:  S Shu; T Provost; M B Croxdale; M Reichlin; E H Beutner
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

4.  Antibody penetration into living cells. I. Intranuclear immunoglobulin in peripheral blood mononuclear cells in mixed connective tissue disease and systemic lupus erythematosus.

Authors:  D Alarcón-Segovia; A Ruíz-Argüelles; E Fishbein
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

5.  Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis.

Authors:  C Krishnan; M H Kaplan
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

6.  IgA localisation in glomerular diseases.

Authors:  W Lawler; G Williams; P Tarpey; E J Acheson; N P Mallick
Journal:  J Clin Pathol       Date:  1977-10       Impact factor: 3.411

7.  False-negative anti-DNA antibody activity in infantile systemic lupus erythematosus (SLE).

Authors:  S C Jordan; J M Lemire; W Border; R Sakai; R B Ettenger; R N Fine
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

8.  Natural autoantibodies in systemic lupus erythematosus.

Authors:  P Matsiota; P Druet; P Dosquet; B Guilbert; S Avrameas
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

9.  Inhibition of adenovirus DNA synthesis in vitro by sera from patients with systemic lupus erythematosus.

Authors:  M S Horwitz; B R Friefeld; H D Keiser
Journal:  Mol Cell Biol       Date:  1982-12       Impact factor: 4.272

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.